Effect of intravenous lidocaine infusion on anesthetic dosage and postoperative recovery quality in laparoscopic appendectomy

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000038542

Enrollment

Unknown

Registered

2020-09-23

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

laparoscopic appendectomy

Interventions

Control group:0.9% normal salt solution

Lidocaine group:Lidocaine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients were eligible to participate if they had an ASA (American Society of Anaesthesiologists)classification 1–2, aged 20–60 years

Exclusion criteria

Exclusion criteria: Patients were ineligible if they had a body mas index > 30 and < 18.5, significant cardiovascular, hepatic or renal disease, arrhythmias, epilepsy, history of alcohol or drug abuse, anxiety or mental disorders, known lidocaine allergy, and pregnancy

Design outcomes

Primary

Measure	Time frame
Sedative consumption;	—

Secondary

Measure	Time frame
(Quality of Recovery-40 Questionnaire, Qo R-40);Time of first exhaust and defecation;Visual Analogue Score, VAS;	—

Countries

China

Contacts

Public ContactXUEJUN ZHANG

Department of Anesthesiology Liaocheng People's Hospital

lcrmzxj@sina.com+86 15275662176

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026